China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- New self-powered sensing system sheds light on environmental monitoring
- Heavy rains leave 3 missing in Central China underground garage
- Report suggests stringent labor laws to protect gig workers
- Film, TV experts highlight global appeal of 'super IPs'
- China expels Philippine vessel attempting to intrude into Huangyan Island waters
- China issues red alert for mountain torrents
